The role of basic leucine zipper transcription factor E4BP4 in cancer: a review and update
Liang Wang1, Peifen Li1, Xueying Zhang1
1Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, School of Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, China.
Abstract:
Mutations in the genes of tumor cells and the disorder of immune microenvironment are the main factors of tumor development. The sensitivity of tumor cells to chemotherapy drugs affect the treatment of tumor. Nuclear transcription factor E4BP4 is dysregulated in a variety of malignant tumors. It can suppress the transcription of NFKBIA, RASSF8, SOSTDC1, FOXO-induced genes (TRAIL, FAS, GADD45a and GADD45b) and Hepcidin, up-regulate RCAN1-1 and PRNP, activate mTOR and p38 in cancer cells. Also, E4BP4 can regulate tumor immune microenvironment. TGFb1/Smad3/E4BP4/ IFNγ axis in NK cells plays an important role in antitumor immunotherapy. Over expression of E4BP4 inhibited the development of Th17 cells by directly binding to the RORγt promoter. Moreover, recent studies have shown that E4BP4 inhibited the expression of multidrug resistance genes. In this review, we summarize the molecular mechanism of E4BP4 in cancer cellular process, the effects of E4BP4 in cancer immunotherapy and antitumor drug resistance, to provide theoretical basis for tumor treatment strategies targeting E4BP4.
Insights
Nuclear transcription factor E4BP4 (E4BP4) impacts tumor growth and immune response. Targeting E4BP4 shows promise for enhancing cancer immunotherapy and overcoming drug resistance.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumor development is driven by genetic mutations and immune microenvironment dysregulation.
- Nuclear transcription factor E4BP4 (E4BP4) is frequently dysregulated in various cancers.
- E4BP4 influences cancer cell processes and the tumor immune microenvironment.
Purpose of the Study:
- To review the molecular mechanisms of E4BP4 in cancer.
- To explore E4BP4's role in cancer immunotherapy.
- To examine E4BP4's impact on antitumor drug resistance.
Main Methods:
- Literature review of studies on E4BP4 in cancer.
- Analysis of E4BP4's transcriptional targets and signaling pathways.
- Examination of E4BP4's role in immune cell regulation and drug resistance.
Main Results:
- E4BP4 regulates key genes involved in cell proliferation and apoptosis.
- E4BP4 modulates the tumor immune microenvironment, including NK cells and Th17 cells.
- E4BP4 expression is linked to inhibition of multidrug resistance genes.
Conclusions:
- E4BP4 plays a multifaceted role in cancer progression, immune evasion, and drug resistance.
- Targeting E4BP4 presents a potential therapeutic strategy for cancer treatment.
- Further research into E4BP4 mechanisms can inform novel antitumor strategies.
Related Concept Videos
Master Transcription Regulators
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Abnormal Proliferation
Epigenetic Regulation
General Transcription Factors


